Several recent studies have suggested HRT is a risk factor in various conditions, notably Alzheimer's - now UK boffins have ...
Professor Markus Sauer from the Biocentre of Julius-Maximilians-Universität (JMU) Würzburg in Bavaria, Germany ...
GLP-1 drugs, widely used for treating metabolic disorders, often face issues with long term tolerability, leading to side effects such as sarcopenia and bone density loss. These complications ...
Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...
New treatments like dotinurad provide safer, more effective solutions for millions battling gout and hyperuricemia.
A breakthrough in prostate cancer treatment has seen a drug shrink tumours in advanced disease ...
The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with ...
Zacks.com on MSN1d
DNLI's Hunter Syndrome Drug Gets Breakthrough Therapy DesignationDenali Therapeutics Inc. DNLI announced that the FDA has granted Breakthrough Therapy Designation to its pipeline candidate, ...
Biologics License Application acceptance supported by results from the Phase 3 Vivacity-MG3 study Results demonstrate sustained disease control over 24 weeks in a broad ...
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced a significant milestone for its proprietary Nectin-4 targeted ADC (9MW2821). On January 8, 2025, ...
My tailored session combined life coaching, hypnotherapy, meditation, breathwork, vision-crafting skills and strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback